PLACEHOLDER: Free shipping over $XX — confirm threshold

Topical cosmetics and devices only — not for injection

Cellular Sequence

Peptide Encyclopaedia

For research purposes onlyInvestigationalNot approved for human use

Cagrilintide

Research / investigational listing only. This compound is not available for consumer purchase from Cellular Sequence and must not be confused with shop products.

Research / investigational compoundThis compound does not have an established approved therapeutic dosing schedule. Doses below describe those reported in published scientific research and should not be interpreted as a treatment recommendation.

At-a-glance profile

Classification
Long-acting amylin analogue (investigational)
Approval status
Investigational · Not approved for human use
Research status
Investigational / reference listing.
Molecular formula
Insufficient reliable evidence identified.
Molecular weight
Insufficient reliable evidence identified.
Sequence
Acylated amylin analogue designed for once-weekly development programmes.
Primary biological target
Insufficient reliable evidence identified.
Half-life
Insufficient reliable evidence identified.
Routes investigated
Insufficient reliable evidence identified.
Human evidence level
C — Limited or early human evidence

What is it?

Investigational metabolic peptide, often studied with semaglutide. Not sold here.

Mechanism of action

Amylin-receptor agonism affecting satiety and gastric emptying.

Experimental metabolic pharmacology.

What is it being studied for?

  • Obesity (with/without incretins)

Investigational findings are not proven clinical benefits unless an authority has labelled that indication.

Evidence level

Overall human evidence grade: C · Limited or early human evidence

Human research

Clinical development exists; not an approved stand-alone shop product.

Preclinical research

Animal, cell and in-vitro findings are listed separately from human effects.

Amylin biology is established.

Doses reported in published research

This section does not provide personalised medical dosing. Values are those reported in papers or protocols. Animal mg/kg doses are not converted to human doses.

Doses reported in human studies

Insufficient reliable evidence identified.

Preclinical / animal study dosing

Insufficient reliable evidence identified.

Pharmacokinetics

Reliable human pharmacokinetic data were not identified for this encyclopaedia entry, or are limited to product information for approved presentations.

Safety

Nausea and GI effects expected in class.

Unknowns. Absence of a published harm signal is not evidence of safety.

Contraindications. Not for unapproved human use.

Regulatory status

Investigational.

Not an ARTG weight-loss medicine. Educational only.

Citations

  1. [1] Encyclopaedia note

    Encyclopaedia note

For educational and research reference only. This page summarises published scientific literature and does not constitute medical advice, prescribing information or a recommendation to use an investigational compound. Research doses shown describe doses reported in published studies and are not personalised dosing instructions.

Last reviewed 2026-09-13. Research areas: Metabolic · Compare peptides